Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study, 2022
Discussion in 'Long Covid research' started by SNT Gatchaman, Jan 14, 2023.
Discussion in 'Long Covid research' started by SNT Gatchaman, Jan 14, 2023.